FINANCIALS

LGNYZ Ligand Pharmaceuticals Inc 886163

Income Statement
Revenue	lgnd-20240930	51,812,000
Net Income	lgnd-20240930	-7,172,000
Profit Margin		-13.84%

Balance Sheet
Current Assets	309,388,000
Assets	954,866,000
Current Liabilities	24,772,000
Liabilities	113,688,000
Equity	841,178,000

Cash Flow Statement
Operating Cash Flow	68,576,000
Investing Cash Flow	-105,041,000

Market Analysis
BVPS	10431.39
PB	0.04
PS	0.64
FCF	-36,465,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view LGNYZ documents filed with the SEC.

LGNYZ Filings Clear

View A List of Tickers